Nyxoah S.A (NYXH): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Nyxoah, S.A. (NYXH)

P/S levels on the chart help assess the business valuation relative to revenue, with 2.80 representing the most recent level. Nyxoah S.A. (NYXH) operates within a stable Western jurisdiction free from political threats. Growth is expected following FDA approval of the Genio system and the expansion of insurance coverage. However, slow adoption of neurostimulation and pressure from traditional therapy methods create certain commercial risks.

Rasio rega marang pendapatan: Nyxoah (NYXH) kanggo 04.07.2022 - 17.11.2026

Rincian metrik lan analitis perusahaan Nyxoah (NYXH)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:Nyxoah SA
Produk seri nyxoah.com

The P/S ratio determines the market value of a business relative to its annual sales volume, allowing for an assessment of the premium paid for every dollar of revenue. By analyzing the P/S trajectory, an investor compares the market capitalization of Nyxoah S.A. (NYXH) with the sales efficiency of its apnea therapy implants, while accounting for costs associated with environmental production upgrades and the disposal of specific medical waste.

Pesaing Nyxoah S.A.

Kapitalisasi marang volume dodolan ISRG|Danaher Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S Becton Dickinson & Company BDX|STE - Rasio rega marang pendapatan|West Pharmaceutical Services (WST) - Kapitalisasi marang pendapatan|BAX: Multiplikator P/S|Kapitalisasi marang pendapatan Masimo|STVN (stevanatogroup.com) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan TFX (Teleflex Incorporated)|Rasio rega marang pendapatan Merit Medical (MMSI)|Envista - Rasio kapitalisasi marang pendapatan|ICU Medical, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan XRAY (Dentsply Sirona Inc)|LMAT - Rasio rega marang pendapatan|Koefisien rega marang pendapatan AtriCure Corp ATRC|staar.com (STAA) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ChromaDex Corporation|ZIMV (ZimVie Inc) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ANGO (AngioDynamics)|Rasio rega marang pendapatan Cerus Corp (CERS)|TKNO: Rasio rega marang dodolan|Rasio rega marang pendapatan Monogram Technologies Inc. MGRM|Rasio kapitalisasi pasar marang pendapatan STSS|INFU - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan UTMD (Utah Medical Products Inc.)|KORU Medical Systems Inc. (KRMD) - Rasio rega marang pendapatan|MBOT (Microbot Medical, Inc) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan PDEX|ZTEK: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELUT|Milestone Scientific Inc. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan NEXGEL, Inc. NXGL|Retractable Tech - Rasio rega marang pendapatan|harvardbioscience.com - Multiplikator P/S|FEMY (Femasys Inc.) - Rasio kapitalisasi marang pendapatan|MHUA: Multiplikator P/S|Predictive Oncology Corp - Rasio kapitalisasi pasar marang pendapatan|CJMB (Callan JMB) - Multiplikator P/S|Rega marang dodolan Atrion Corporation Inc. ATRI|Multiplikator P/S NURO